The presentations will feature 3-month and 6-month endpoints clinical data from the Phase IIa (NCT06233474) for Allocetra™ in patients with moderate-to-severe knee osteoarthritis (KOA). The Phase IIa ...
TNX-1700 (TFF2-albumin fusion protein) reversed aging-associated gastric inflammation and significantly attenuated tumor progression in aged ...
Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...
The next steps for a proposed Central Avenue roundabout are on hold after a tied council vote to award the design contract pushed the decision, potentially to next year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results